HB 2112 Summary

• Prohibits manufacturers and wholesale distributors from engaging in "price gouging" on essential off-patent or generic drugs, defined as unconscionable price increases not justified by production costs or expansion of drug access.

• Requires manufacturers to submit detailed statements to the Attorney General within 45 days when requested, itemizing production costs and explaining any price increases and expenditures to expand drug access.

• Authorizes the Attorney General to pursue court orders to enjoin price gouging violations, compel production of records, restore consumer monies, and impose civil penalties up to $10,000 per violation.

• Allows the state medical assistance program to notify the Attorney General of price increases meeting specific thresholds: at least 50% increase within one year, and resulting in drug costs exceeding $80 for a 30-day supply or full treatment course.

• Requires the Attorney General to provide manufacturers an opportunity to justify price increases before pursuing enforcement actions under the article.